Journal of Neurogastroenterology and Motility

The Korean Society of Neurogastroenterology and Motility (대한소화기 기능성질환 운동학회)
권호 표지
DOI QR코드

DOI QR Code

Duodenal Implications in the Pathophysiology of Functional Dyspepsia

  • Lee, Kwang-Jae (Department of Gastroenterology, Ajou University School of Medicine) ;
  • Tack, Jan (Division of Gastroenterology, Department of Internal Medicine, University of Leuven)
  • Published : 2010.07.30
⟨ Previous Next ⟩

Abstract

Functional dyspepsia (FD) is a heterogeneous disorder associated with diverse pathophysiologic mechanisms. Studies have shown duodenal implications in the pathophysiology of FD. Duodenal hypersensitivity to acid, increased duodenal acid exposure, and abnormal responses to duodenal lipids or released cholecystokinin have been observed in patients with FD. Moreover, there is evidence indicating duodenal immune activation in FD. Alterations in the number of duodenal eosinophils or intraepithelial lymphocytes have been reported in a subset of FD patients, particularly in patients with post-infectious FD. Whether these abnormalities in the duodenum play a crucial role in the generation of dyspeptic symptoms needs to be elucidated. Further investigations on the relationship between duodenal abnormalities and well-known pathophysiologic mechanisms of FD are required. Furthermore, the causative factors related to the development of duodenal abnormalities in FD warrant further study.

Keywords

References

  1. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479. https://doi.org/10.1053/j.gastro.2005.11.059
  2. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-1042. https://doi.org/10.1053/gast.1996.v110.pm8612991
  3. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003;98:783-788. https://doi.org/10.1111/j.1572-0241.2003.07389.x
  4. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-1352. https://doi.org/10.1016/S0016-5085(98)70012-5
  5. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001;121:526-535. https://doi.org/10.1053/gast.2001.27180
  6. Haug TT, Svebak S, Wilhelmsen I, et al. Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosom Res 1994;38:281-291. https://doi.org/10.1016/0022-3999(94)90033-7
  7. Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999;116:515-520. https://doi.org/10.1016/S0016-5085(99)70171-X
  8. Lee KJ, Demarchi B, Demedts I, Sifrim D, Raeymaekers P, Tack J. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol 2004;99:1765-1773. https://doi.org/10.1111/j.1572-0241.2004.30822.x
  9. Bratten J, Jones MP. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system. J Clin Gastroenterol 2009;43:527-533. https://doi.org/10.1097/MCG.0b013e31818e37ab
  10. Fried M, Feinle C. The role of fat and cholecystokinin in functional dyspepsia. Gut 2002;51(suppl 1):i54-i57.
  11. Bjornsson E, Sjoberg J, Ringstrom G, Norstrom M, Simren M, Abrahamsson H. Effects of duodenal lipids on gastric sensitivity and relaxation in patients with ulcer-like and dysmotility-like dyspepsia. Digestion 2003;67:209-217. https://doi.org/10.1159/000072059
  12. Talley NJ, Walker MM, Aro P, et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007;5:1175-1183. https://doi.org/10.1016/j.cgh.2007.05.015
  13. Kindt S, Tertychnyy A, de Hertogh G, Geboes K, Tack J. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 2009;21:832-e856. https://doi.org/10.1111/j.1365-2982.2009.01299.x
  14. Collen MJ, Loebenberg MJ. Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis. Dig Dis Sci 1989;34:246-250. https://doi.org/10.1007/BF01536059
  15. George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 1991;101:3-6.
  16. Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-1065. https://doi.org/10.1046/j.1365-2036.1998.00410.x
  17. di Stefano M, Vos R, Vanuytsel T, Janssens J, Tack J. Prolonged duodenal acid perfusion and dyspeptic symptom occurrence in healthy volunteers. Neurogastroenterol Motil 2009;21:712-e740. https://doi.org/10.1111/j.1365-2982.2009.01274.x
  18. Lee KJ, Kim JH, Cho SW. Dyspeptic symptoms associated with hypersensitivity to gastric distension induced by duodenal acidification. J Gastroenterol Hepatol 2006;21:515-520. https://doi.org/10.1111/j.1440-1746.2005.03976.x
  19. Bratten J, Jones MP. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system. J Clin Gastroenterol 2009;43:527-533. https://doi.org/10.1097/MCG.0b013e31818e37ab
  20. Akiba Y, Kaunitz JD. Luminal chemosensing and upper gastrointestinal mucosal defenses. Am J Clin Nutr 2009;90:826S-831S. https://doi.org/10.3945/ajcn.2009.27462U
  21. Mayer EA and Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-293.
  22. Lee KJ, Vos R, Janssens J, Tack J. Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol 2004;286:G278-G284. https://doi.org/10.1152/ajprenal.00139.2003
  23. Schwarz MP, Samsom M, Smout AJPM. Chemospecific alterations in duodenal perception and motor response in functional dyspepsia. Am J Gastroenterol 2001;96:2596-2602. https://doi.org/10.1111/j.1572-0241.2001.04103.x
  24. Houghton LA, Kerrigan DD, Read NW. Effect of intraduodenal infusion of acid on the antropyloroduodenal motor unit in human volunteers. J Gastrointest Motil 1990;2:202-208.
  25. Hunt JN, Knox MT. The slowing of gastric emptying by four strong acids and three weak acids. J Physiol 1972;222:187-208.
  26. Lin HC, Doty JE, Reedy TJ, et al. Inhibition of gastric emptying by acids depends on pH, titratable acidity, and length of intestine exposed to acid. Am J Physiol 1990;259:G1025-G1030.
  27. Woodtli W, Owyang C. Duodenal pH governs interdigestive motility in humans. Am J Physiol 1995;268:G146-G152.
  28. Lemon M, Dedering JP, Flourie B, et al. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. Dig Dis Sci 1991;36:1249-1254. https://doi.org/10.1007/BF01307517
  29. Barbera R, Feinle C, Read NW. Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 1995;7:1051-1057. https://doi.org/10.1097/00042737-199511000-00007
  30. Feinle C, Grundy D, Read NW. Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension. Am J Physiol 1997;273:G721-G726.
  31. Barbera R, Feinle C, Read NW. Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia. Dig Dis Sci 1995;40:1636-1641. https://doi.org/10.1007/BF02212683
  32. Barbera R, Peracchi M, Brighenti F, Cesana B, Bianchi PA, Basilisco G. Sensations induced by medium and long chain triglycerides: role of gastric tone and hormones. Gut 2000;46:32-36. https://doi.org/10.1136/gut.46.1.32
  33. Feinle C, Meier O, Otto B, D'Amato M, Fried M. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001;48:347-355. https://doi.org/10.1136/gut.48.3.347
  34. Chua AS, Keeling PW, Dinan TG. Role of cholecystokinin and central serotonergic receptors in functional dyspepsia. World J Gastroenterol 2006;12:1329-1335.
  35. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005;22:847-853. https://doi.org/10.1111/j.1365-2036.2005.02658.x
  36. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in man. Gut 2006;55:327-333. https://doi.org/10.1136/gut.2004.060426
  37. Binn M, Albert C, Gougeon A, et al. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 2006;27:1603-1606. https://doi.org/10.1016/j.peptides.2005.12.008
  38. Murray CD, Martin NM, Patterson M, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo-controlled crossover study. Gut 2005;54:1693-1698. https://doi.org/10.1136/gut.2005.069088
  39. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol 2004;287:E297-E304.
  40. Lee KJ, Cha DY, Cheon SJ, Yeo M, Cho SW. Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia. Digestion 2009;80:58-63. https://doi.org/10.1159/000215389
  41. Piliponsky AM, Pickholtz D, Gleich GJ, Levi-Schaffer F. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol 2001;107:993-1000. https://doi.org/10.1067/mai.2001.114656
  42. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702. https://doi.org/10.1053/j.gastro.2003.11.055
  43. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008;23:1689-1694. https://doi.org/10.1111/j.1440-1746.2008.05574.x
  44. Guilarte M, Santos J, de Torres I, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007;56:203-209. https://doi.org/10.1136/gut.2006.100594
  45. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006;24:147-174. https://doi.org/10.1146/annurev.immunol.24.021605.090720
  46. Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007;132:26-37. https://doi.org/10.1053/j.gastro.2006.11.039
  47. Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol 2010;7:146-156. https://doi.org/10.1038/nrgastro.2010.5
  48. Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009;29:765-773. https://doi.org/10.1111/j.1365-2036.2009.03937.x
  49. Martin ST, Collins CG, Fitzgibbon J, Lee G, Quigley EM, O'Sullivan GC. Gastric motor dysfunction: is eosinophilic mural gastritis a causative factor? Eur J Gastroenterol Hepatol 2005;17:983-986. https://doi.org/10.1097/00042737-200509000-00015
  50. Murch S. Allergy and intestinal dysmotility-evidence of genuine causal linkage? Curr Opin Gastroenterol 2006;22:664-668. https://doi.org/10.1097/01.mog.0000245546.18279.7e
  51. Hogan SP, Mishra A, Brandt EB, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol 2001;2:353-360.
  52. Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005;129:98-104. https://doi.org/10.1053/j.gastro.2005.04.012
  53. Tack J, Demedts I, Dehondt G, et al. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002;122:1738-1747. https://doi.org/10.1053/gast.2002.33663
  54. Gargala G, Lecleire S, Francois A. Duodenal intraepithelial T lymphocytes in patients with functional dyspepsia. World J Gastroenterol 2007;13:2333-2338.
  55. Suzuki H. Post-infectious functional dyspepsia - A novel disease entity among functional gastrointestinal disorders - Relation to Helicobacter pylori infection? J Neurogastroenterol Motil 2010;16:97-98. https://doi.org/10.5056/jnm.2010.16.1.97

Cited by

  1. The Role of Eosinophils and Mast Cells in Intestinal Functional Disease vol.13, pp.4, 2010, https://doi.org/10.1007/s11894-011-0197-5
  2. Functional dyspepsia vol.27, pp.6, 2010, https://doi.org/10.1097/mog.0b013e32834b7ca8
  3. Enteropatía sensible al gluten y dispepsia funcional vol.35, pp.2, 2010, https://doi.org/10.1016/j.gastrohep.2011.10.006
  4. Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial vol.13, pp.None, 2010, https://doi.org/10.1186/1472-6882-13-54
  5. Efficacy of Modified Ban Xia Xie Xin Decoction on Functional Dyspepsia of Cold and Heat in Complexity Syndrome: A Randomized Controlled Trial vol.2013, pp.None, 2013, https://doi.org/10.1155/2013/812143
  6. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia vol.63, pp.2, 2010, https://doi.org/10.1136/gutjnl-2012-303857
  7. Helicobacter pylori Infection Impacts on Functional Dyspepsia in Thailand vol.15, pp.24, 2010, https://doi.org/10.7314/apjcp.2014.15.24.10887
  8. Dysbiotic infection in the stomach vol.21, pp.40, 2010, https://doi.org/10.3748/wjg.v21.i40.11450
  9. Association of the Extent of Atrophic Gastritis With Specific Dyspeptic Symptoms vol.21, pp.4, 2010, https://doi.org/10.5056/jnm15074
  10. Diet and Nutritional Management in Functional Gastrointestinal Disorder: Functional Dyspepsia vol.90, pp.2, 2010, https://doi.org/10.3904/kjm.2016.90.2.98
  11. Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study vol.22, pp.2, 2016, https://doi.org/10.5056/jnm15178
  12. Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria vol.22, pp.3, 2010, https://doi.org/10.5056/jnm15174
  13. Reizdarm und Reizmagen - Pathophysiologie und Biomarker vol.12, pp.2, 2010, https://doi.org/10.1007/s11377-017-0143-7
  14. FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats vol.313, pp.2, 2010, https://doi.org/10.1152/ajpgi.00041.2017
  15. Functional Abdominal Pain vol.6, pp.1, 2010, https://doi.org/10.1007/s40124-018-0158-7
  16. Choosing an Animal Model for the Study of Functional Dyspepsia vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/1531958
  17. An Herbal Medicine, Yukgunja-Tang is more Effective in a Type of Functional Dyspepsia Categorized by Facial Shape Diagnosis: A Placebo-Controlled, Double-Blind, Randomized Trial vol.2018, pp.None, 2010, https://doi.org/10.1155/2018/8546357
  18. Quantitative Analysis of Distribution of the Gastrointestinal Tract Eosinophils in Childhood Functional Abdominal Pain Disorders vol.24, pp.4, 2010, https://doi.org/10.5056/jnm18050
  19. Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift vol.24, pp.3, 2018, https://doi.org/10.5056/jnm18060
  20. Systematic review: Disease‐specific instruments to assess gastrointestinal symptoms in functional dyspepsia vol.30, pp.8, 2010, https://doi.org/10.1111/nmo.13327
  21. DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia vol.19, pp.12, 2010, https://doi.org/10.3390/ijms19124035
  22. Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center vol.54, pp.4, 2010, https://doi.org/10.1007/s00535-019-01550-4
  23. Duodenal Chemosensing of Short-Chain Fatty Acids: Implications for GI Diseases vol.21, pp.8, 2010, https://doi.org/10.1007/s11894-019-0702-9
  24. Clinical Practice Guidelines for Functional Dyspepsia in Korea vol.26, pp.1, 2010, https://doi.org/10.5056/jnm19209
  25. Duodenal inflammation: an emerging target for functional dyspepsia? vol.24, pp.6, 2020, https://doi.org/10.1080/14728222.2020.1752181
  26. Duodenal mucosal secretory disturbances in functional dyspepsia vol.33, pp.1, 2010, https://doi.org/10.1111/nmo.13955
  27. Eosinophil-associated microinflammation in the gastroduodenal tract contributes to gastric hypersensitivity in a rat model of early-life adversity vol.320, pp.2, 2010, https://doi.org/10.1152/ajpgi.00313.2020
  28. Clinical Practice Guidelines for the Treatment of Functional Dyspepsia in Korea vol.96, pp.2, 2021, https://doi.org/10.3904/kjm.2021.96.2.116
  29. The Usefulness of Symptom-based Subtypes of Functional Dyspepsia for Predicting Underlying Pathophysiologic Mechanisms and Choosing Appropriate Therapeutic Agents vol.27, pp.3, 2010, https://doi.org/10.5056/jnm21042